✦ LIBER ✦

Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer

✍ Scribed by Ayca Gucalp; Joseph A. Sparano; James Caravelli; Jean Santamauro; Sujata Patil; Alyson Abbruzzi; Christine Pellegrino; Jackie Bromberg; Chau Dang; Maria Theodoulou; Joan Massague; Larry Norton; Clifford Hudis; Tiffany A. Traina

Book ID: 113538922
Publisher: CIG Media Group, LP.
Year: 2011
Tongue: English
Weight: 477 KB
Volume: 11
Category: Article
ISSN: 1526-8209
DOI: 10.1016/j.clbc.2011.03.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of the Src kinase inhib

A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium

✍ Helen J. Mackay, Heather J. Au, Elaine McWhirter, Thierry Alcindor, Andrea Jarvi 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 116 KB

Phase II Trial of Bicalutamide in Patien

Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer

✍ Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; 📂 Article 📅 2013 🏛 American Association for Cancer Research 🌐 English ⚖ 312 KB

A phase II, randomized, open-label, pilo

A phase II, randomized, open-label, pilot study to evaluate the safety and the effects on bone resorption of saracatinib (AZD0530) in patients with prostate cancer or breast cancer with metastatic bone disease

✍ M. Aklilu*; A. Hussain; C.P. Evans; R.A. Hannon; A. Lipton; M. Dimairo; J. Yu; P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Phase II Trial of Fulvestrant With Metro

Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

✍ Schwartzberg, Lee S.; Wang, Grace; Somer, Bradley G.; Blakely, L. Johnetta; Whee 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 276 KB

Oral Gossypol in the Treatment of Patien

Oral Gossypol in the Treatment of Patients with Refractory Metastatic Breast Cancer: A Phase I/II Clinical Trial

✍ Catherine Van Poznak; Andrew D. Seidman; Marcus M. Reidenberg; Mark M. Moasser; 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 180 KB

Phase I trial of the oral PARP inhibitor

Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer

✍ Dent, Rebecca A; Lindeman, Geoffrey J; Clemons, Mark; Wildiers, Hans; Chan, Arle 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 207 KB